GE scores first Senographe installation
GE Medical Systems has made its first commercial installation of Senographe 2000D, the company’s full-field digital mammography system. The unit received the CE Mark for European regulatory clearance this spring (SCAN 3/17/99), and on Sept. 2
GE Medical Systems has made its first commercial installation of Senographe 2000D, the companys full-field digital mammography system. The unit received the CE Mark for European regulatory clearance this spring (SCAN 3/17/99), and on Sept. 2 Senographe was placed at Charite Hospital in Berlin. The Milwaukee-based firm plans to install more than 50 Senographes outside the U.S. by the end of the year.
Senographe 2000Ds digital detector is based on amorphous silicon flat-panel detectors manufactured in the companys plant in Santa Clara, CA, a joint venture between GE and EG&G Amorphous Silicon (SCAN 9/3/97) The detectors are then shipped to France, where they are incorporated into Senographe systems built at the companys x-ray and mammography factory in Buc.
AI-Initiated Recalls After Screening Mammography Demonstrate Higher PPV for Breast Cancer
March 18th 2025While recalls initiated by one of two reviewing radiologists after screening mammography were nearly 10 percent higher than recalls initiated by an AI software, the AI-initiated recalls had an 85 percent higher positive predictive value for breast cancer, according to a new study.
ECR Mammography Study: Pre-Op CEM Detects 34 Percent More Multifocal Masses than Mammography
February 28th 2025In addition to contrast-enhanced mammography (CEM) demonstrating over a 90 percent detection rate for multifocal masses, researchers found that no significant difference between histological measurements and CEM, according to study findings presented at the European Congress of Radiology.
Study: Mammography AI Leads to 29 Percent Increase in Breast Cancer Detection
February 5th 2025Use of the mammography AI software had a nearly equivalent false positive rate as unassisted radiologist interpretation and resulted in a 44 percent reduction in screen reading workload, according to findings from a randomized controlled trial involving over 105,000 women.
